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OBJECTIVEdTo investigate if there is a reduced risk of type 1 diabetes in children breastfed or
exclusively breastfed by performing a pooled analysis with adjustment for recognized confounders.
RESEARCHDESIGNANDMETHODSdRelevant studies were identiﬁed from literature
searches using MEDLINE, Web of Science, and EMBASE. Authors of relevant studies were asked
to provide individual participant data or conduct prespeciﬁed analyses. Meta-analysis techniques
were used to combine odds ratios (ORs) and investigate heterogeneity between studies.
RESULTSdData were available from 43 studies including 9,874 patients with type 1 diabetes.
Overall, there was a reduction in the risk of diabetes after exclusive breast-feeding for.2 weeks
(20 studies; OR = 0.75, 95% CI 0.64–0.88), the association after exclusive breast-feeding for.3
months was weaker (30 studies; OR = 0.87, 95%CI 0.75–1.00), and no association was observed
after (nonexclusive) breast-feeding for.2 weeks (28 studies; OR = 0.93, 95% CI 0.81–1.07) or
.3 months (29 studies; OR = 0.88, 95% CI 0.78–1.00). These associations were all subject to
marked heterogeneity (I2 = 58, 76, 54, and 68%, respectively). In studies with lower risk of bias,
the reduced risk after exclusive breast-feeding for .2 weeks remained (12 studies; OR = 0.86,
95% CI 0.75–0.99), and heterogeneity was reduced (I2 = 0%). Adjustments for potential con-
founders altered these estimates very little.
CONCLUSIONSdThe pooled analysis suggests weak protective associations between exclu-
sive breast-feeding and type 1 diabetes risk. However, these ﬁndings are difﬁcult to interpret
because of the marked variation in effect and possible biases (particularly recall bias) inherent in
the included studies.
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Childhood type 1 diabetes is causedby the autoimmune destruction ofthe pancreatic b-cells. The increases
in type 1 diabetes incidence in recent dec-
ades (1) and the concordance rate of
,50% in monozygotic twins (2) sug-
gests a role for environmental factors in
the development of diabetes. The propor-
tional greater relative increases in inci-
dence in children ,5 years old (1)
indicates that environmental exposures
in early life, such as infant feeding, could
play an important role.
In 1994, a meta-analysis (3) con-
cluded that breast-feeding for a short pe-
riod reduced the risk of type 1 diabetes by
40%, but another meta-analysis in 1996
(4), largely containing the same studies,
concluded that the weak reduction in di-
abetes risk after breast-feeding was small
and may have methodological explana-
tions. However, both these meta-analyses
had limitations. The associations with
type 1 diabetes (extracted from published
studies) were based upon categorized
durations of breast-feeding, which dif-
fered between studies. Furthermore, in
these meta-analyses, it was not possible
to adjust the association between breast-
feeding and type 1 diabetes consistently
for potential confounders (factors such as
maternal age, birth weight, and maternal
diabetes that were associated with both
diabetes risk and the propensity to breast-
feed). Also, studies that recorded breast-
feeding results but did not report them in
sufﬁcient detail were excluded, potentially
exaggerating any breast-feeding association
through reporting bias. These weaknesses
were largely because both were literature-
based meta-analyses (based only upon
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reported associations in published stud-
ies) rather than collaborative meta-analyses
or pooled analyses (using individual
participant data from included studies
after contacting authors of articles con-
taining relevant data) (5). Since the publi-
cation of these two meta-analyses, many
additional observational studies have in-
vestigated breast-feeding and type 1 dia-
betes, allowing a new meta-analysis to be
conducted on an independent group of
more recent studies.
The aim of this study was to assess the
evidence of an association between dura-
tion of breast-feeding (and exclusive
breast-feeding) and type 1 diabetes using
collaborative meta-analysis techniques
from observational studies published
since 1996. Importantly, this pooled
analysis includes individual participant
data, allowing consistent categorization of
breast-feeding across studies and adjust-
ment for potential confounders such as
maternal age, birth weight, and maternal
diabetes and will also include studies
investigating breast-feeding but not re-
porting detailed results.
RESEARCH DESIGN AND
METHODS
Literature search
The main literature search was conducted
using MEDLINE through Ovid Online.
The search was adapted from a previous
study (6) and comprised search terms for
infant feeding consisting of text words
(including breast fed, breast feed, breast
feeds, breast feeding, breast milk, bottle
fed, bottle feed, bottle feeds, bottle feed-
ing, infant feed, infant feeds, infant feed-
ing, infant nutrition, formula fed, formula
feed, formula feeds, formula feeding, in-
fant diet, infant diets, dried milk, and
early nutrition) or MEDLINE subject
heading key words (including breast
feeding, bottle feeding, milk, human, in-
fant food, and infant formula) and terms
for type 1 diabetes including the text
words (IDDM or [diabetes and type 1])
or the MEDLINE subject heading key
word “diabetes mellitus, type 1.” Similar
searches were conducted on Web of Sci-
ence and EMBASE. The searches were
limited to studies on humans published
after January 1996 [to avoid overlap with
two previous meta-analyses (3,4)] up to 1
May 2011. No language restrictions were
applied. Titles and then abstracts were
screened independently by two investigators
(C.R.C. and C.C.P.) to establish if the
studies were likely to provide relevant
data based on the following inclusion cri-
teria: 1) they identiﬁed a group with type
1 diabetes and a group without type 1
diabetes, and 2) they recorded breast-
feeding in these groups. Studies were ex-
cluded if they contained ,20 patients
with diabetes or if they were family-based
(because the association between infant
feeding and type 1 diabetes may be differ-
ent in individuals with a strong genetic
susceptibility). The corresponding au-
thor of each included article was asked
if they were aware of any additional
studies.
The corresponding author of each
study was contacted to provide individual
participant data to allow breast-feeding to
be consistently categorized across studies,
standardize adjustment of the association
with breast-feeding for potential con-
founders (including maternal diabetes,
birth weight, gestational age, maternal
age, birth order, Caesarean section, and
socioeconomic status), and include data
from studies that did not report detailed
ﬁndings. Authors were requested to pro-
vide raw data or to provide adjusted
estimates of the association between
breast-feeding and type 1 diabetes after
conducting speciﬁed additional analyses.
Details of each study were extracted
by one reviewer (C.R.C.) and agreed with
the study author.
Statistical analysis
A two-stage technique was used to calcu-
late pooled estimates of the association
between breast-feeding and diabetes, be-
fore and after adjustment for potential
confounders (7). Odds ratios (ORs) and
SEs were calculated for the association be-
tween diabetes and breast-feeding within
each study. Unconditional and condi-
tional logistic regression was used to cal-
culate the ORs and SEs for the unmatched
andmatched case-control studies, respec-
tively. In cohort studies with varying
length of participant follow-up, rate ratios
and their SEs were used instead of ORs,
which were not directly calculable. As
type 1 diabetes is a rare disease, these
measures should be approximately equal.
In one study (8) with a zero cell count for
an exposure category, a correction was
added to obtain an estimate and SE for
use in themeta-analysis. In another study,
an additional adjustment was always
made for the perinatal cohort entry score
to reﬂect the study design (9). Finally, in
studies for which no author could be con-
tacted or data were not available, if possi-
ble, required estimates were extracted
from published reports. Meta-analysis
techniques were then applied to these es-
timates. Tests for heterogeneity between
studies were conducted and random-
effects models used to calculate pooled
ORs. Random-effects models were used,
instead of ﬁxed-effects models, because
between-study heterogeneity was antici-
pated from these observational studies.
The I2 statistic was calculated to quantify
the degree of heterogeneity between stud-
ies. Small study effects (possibly due to
publication bias) were investigated by
checking for asymmetry in funnel plots
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Breast-feeding and childhood type 1 diabetes
of the study ORs against one over the SE
of the logarithm of the ORs.
Similar methods were conducted to
pool adjusted estimates. First, adjusted
estimates and SEs were calculated within
each study using regression models ap-
propriate to the study design including
diabetes as the outcome variable and breast-
feeding and the potential confounder(s)
of interest as explanatory variable(s).Meta-
analysis techniques were then applied to
these adjusted estimates.
The analysis was initially conducted
based upon a priori categorizations of non-
exclusive and exclusive breast-feeding $2
weeks versus breast-feeding ,2 weeks
and was repeated for nonexclusive breast-
feeding $3 months versus breast-feeding
,3 months in which these data or similar
were available. Subgroup analyses were
also conducted including only studies
with a low risk of bias based upon high
response rates (.70%) in both cases and
controls and the use of randomly selected
population-based controls. Subgroup anal-
ysis was also performed by age at diagnosis
of diabetes, geographic region, and inci-
dence rate based upon a published sum-
mary of worldwide incidence (10).
All statistical analyses were per-
formed using STATA 11.0 (Stata, College
Station, TX).
RESULTS
Search results
The results from the literature search are
shown in Supplementary Fig. 1. Brieﬂy,
initial searches identiﬁed 238 articles
from MEDLINE, 393 from Web of Sci-
ence, and 609 from EMBASE. Of these,
40 articles contained relevant data from
47 studies, as information from 7 centers
was taken from 1 article (11) and informa-
tion from 2 centers was taken from another
(12). An investigator from each of the 47
studies was invited to provide raw data (or
estimates from prespeciﬁed analyses). Esti-
mates were obtained from 43 of the 47
identiﬁed studies covering 95% (9,874 of
10,390) of potential patients with type 1
diabetes. Individual patient data were ob-
tained from 27 of these studies, 8 supplied
prespeciﬁed estimates, in 8 studies data
could be extracted from published reports,
and 4 studies could not be included.
Characteristics of included studies
Table 1 contains the characteristics of the
43 studies from which relevant data were
obtained (see Supplemental Data for full
list of included articles). Of these, 40 were
case-control studies, and 3 were cohort
studies. Twenty-eight studies were from
Europe, and in 24 studies, cases were
identiﬁed using a national or local diabe-
tes register. Thirty-seven studies ascertained
breast-feeding data using questionnaires
or interviews, and in the majority,
breast-feeding data were recalled many
years after the birth of the child.
Overall ﬁndings for any
(nonexclusive) breast-feeding
The associations between any (nonexclu-
sive) breast-feeding and type 1 diabetes
from the 43 studies (including 9,874
patients with type 1 diabetes) are shown
in Fig. 1 and Table 2. Initially, an analysis
was conducted investigating any recorded
duration of breast-feeding (the breast-
feeding duration used in this analysis
for each study is shown in Fig. 1).
Overall, in studies which investigated
any measure of breast-feeding, there was
a reduction in the risk of type 1 diabetes in
breast-fed children of 18% (OR = 0.81,
95% CI 0.72–0.92; P , 0.001). There
was, however, marked heterogeneity be-
tween studies (I2 = 63%; heterogeneity
P , 0.001). Restricting this analysis to
studies with a low risk of bias (due to
high response rates and randomly selected
population-based controls, as shown in
Table 1), there was no evidence of an as-
sociation (OR = 1.00, 95% CI 0.89–1.11;
P = 0.93) and little evidence of heteroge-
neity (I2 = 1%; heterogeneity P = 0.51).
Analyses were also conducted in sub-
groups of studies recording breast-feeding
of ;2 weeks’ duration or more (see Fig. 1
for exact duration of breast-feeding used in
each study) and ;3 months duration or
more (see Table 1 for exact duration of
breast-feeding used in each study). In 28
studies, there was little evidence of any
difference in the risk of type 1 diabetes
in children breast-fed for ;2 weeks or
more compared with ,2 weeks (OR =
0.93, 95% CI 0.81–1.07; P = 0.32), but
again there was heterogeneity between
studies (I2 = 54%; heterogeneity P ,
0.001). This heterogeneity was reduced
in 15 studies with a low risk of bias (I2 =
8%; heterogeneity P = 0.37), but the over-
all ﬁnding was little altered (OR = 1.00,
95% CI 0.87–1.15; P = 0.99). In 29 stud-
ies, there was also little evidence of a re-
duction in the risk of type 1 diabetes in
children breast-fed for ; 3 months or
more compared with children breast-fed
for ,3 months (OR = 0.88, 95% CI
0.78–1.00; P = 0.05), but the heterogene-
ity between studies persisted (I2 = 68%;
heterogeneity P , 0.001). Repeating this
analysis in 15 studies with a low risk of
bias showed no evidence of an association
(OR = 0.99, 95% CI 0.86–1.14; P = 0.92)
and slightly less, though still signiﬁcant,
heterogeneity (I2 = 48%; heterogeneity
P = 0.02). Funnel plots (not shown) pro-
vided little evidence of asymmetry (poten-
tially caused by publication bias).
Finally, an analysis was conducted in
the following approximate categories of
(nonexclusive) breast-feeding:,2 weeks,
2 weeks to 4 months, 4–6 months, and
.6 months. In 24 studies with available
data, when compared with children
breast-fed for ,2 weeks children breast-
fed for 2 weeks to 4 months had a 4%
reduction in diabetes risk (OR = 0.96,
95% CI 0.83–1.12), children breast-fed
for 4–6 months had a 5% reduction in di-
abetes risk (OR = 0.95, 95%CI 0.78–1.15),
and children breast-fed for .6 months
had a 6% reduction in diabetes risk (OR =
0.94, 95% CI 0.76–1.17), though none of
these differences were signiﬁcant. These
ﬁndings were similar when restricted to
13 studies with a low risk of bias.
Additional analyses (shown in Sup-
plementary Table 2) in subgroups of stud-
ies deﬁned by geographic region
(European, non-European) and low and
high incidence rate countries (,15 cases
of type 1 diabetes per 100,000 person-
years and.15 per 100,000 person-years,
respectively) did not reveal any marked
differences in association.
There was little evidence of a differ-
ence in the association between child-
hood type 1 diabetes and (nonexclusive)
breast-feeding in early diagnosed diabetes
(i.e., ,5 years old) and later diagnosed
diabetes (i.e., between 5 and 15 years
old) in studies in which both age groups
were available (shown in Supplementary
Table 3). Speciﬁcally, in 22 studies, the
OR for breast-feeding for ;2 weeks or
more was 0.84 (95% CI 0.65–1.08) in
early diagnosed disease and 0.95 (95%
CI 0.82–1.11) for later diagnosed disease.
Similarly, in 23 studies, the OR for breast-
feeding for ;3 months or more was 0.86
(95% CI 0.69–1.08) in early diagnosed
disease and 0.90 (95% CI 0.79–1.02) for
later diagnosed disease.
Supplementary Table 1 shows the
ﬁndings for (nonexclusive) breast-feeding
for;2weeks ormore after adjustment for
potential confounders. The association
between type 1 diabetes and breast-feeding
was little altered after individual adjustment
for maternal diabetes, birth weight, ges-
tational age, maternal age, birth order,
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Breast-feeding and childhood type 1 diabetes
Figure 1dPooled analysis of association between (nonexclusive) breast-feeding and childhood-onset type 1 diabetes in studies investigating ;2
weeks (nonexclusive) breast-feeding and studies investigating any measure of breast-feeding.
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Caesarean section delivery, or socio-
economic status, where possible. There
was also little change in the estimate
when adjustment for all available variables
simultaneously was conducted.
Overall ﬁndings for exclusive
breast-feeding
Similar analyses were conducted for the as-
sociations between exclusive breast-feeding
and type 1 diabetes (investigated by 33
studies including 7,621 patients with type
1 diabetes) that are shown in Fig. 2 (which
contains the duration of exclusive breast-
feeding used in each study) and Table 1.
Overall, in studies which investigated any
measure of exclusive breast-feeding, there
was a reduction in the risk of type 1 di-
abetes in exclusively breast-fed children
of 26% (OR = 0.74, 95% CI 0.64–0.84;
P, 0.001), but there was marked hetero-
geneity between studies (I2 = 67%; hetero-
geneity P , 0.001). When restricting this
analysis to 13 studies with a low risk
of bias, the association was no longer sig-
niﬁcant (OR = 0.89, 95% CI 0.78–1.02;
P = 0.09), and there was less heterogeneity
(I2 = 6%; heterogeneity P = 0.38).
As before, analysis was conducted in
subgroups of studies recording;2 weeks
or more (see Fig. 1 for deﬁnition) and;3
months ormore of exclusive breast-feeding
(see Table 1 for deﬁnition). In 20 stud-
ies, children exclusively breast-fed for ;2
weeks or more had a 25% reduction in
their risk of type 1 diabetes (OR = 0.75,
95% CI 0.64–0.88; P = 0.001) compared
with children exclusively breast-fed for
,2 weeks, but there was marked hetero-
geneity between studies (I2 = 58%; het-
erogeneity P , 0.001). This association
was slightly attenuated but remained signif-
icant in 12 studies with a low risk of bias
(OR = 0.86, 95% CI 0.75–0.99; P = 0.04),
but in these studies, there was less hetero-
geneity (I2 = 0%; heterogeneity P = 0.44).
There was less evidence of a reduction in
diabetes risk (in 30 studies) in children ex-
clusively breast-fed for;3months ormore
(OR = 0.87, 95% CI 0.75–1.00; P = 0.06)
compared with children exclusively breast-
fed for ,3 months but there was marked
heterogeneity (I2 = 76%; heterogeneity
P , 0.001). In 13 studies with a low
risk of bias, the heterogeneity remained
(I2 = 43%; heterogeneity P = 0.03), and
there was little evidence of an association
(OR = 1.13, 95%CI 0.96–1.33; P = 0.15).
Insufﬁcient data were available to conduct
an analysis of exclusive breast-feeding in
ﬁner duration categories. Funnel plots for
these associations (not shown) providedT
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Figure 2dPooled analysis of association between exclusive breast-feeding and childhood-onset type 1 diabetes in studies investigating ;2 weeks
exclusive breast-feeding and studies investigating any measure of exclusive breast-feeding.
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little evidence of asymmetry (potentially
caused by publication bias).
Additional analyses (shown in Sup-
plementary Table 2) in subgroups of
studies deﬁned by geographic region (Eu-
ropean, non-European) and incidence
rates of type 1 diabetes (low incidence,
high incidence) did not reveal any
marked differences in association.
As before, a comparison of the asso-
ciations with exclusive breast-feeding by
early diagnosed diabetes (i.e.,,5 years old)
and later diagnosed diabetes (i.e., between
5 and 15 years old) showed little evidence
of a difference in studies in which both age
groups were available (shown in Supple-
mentary Table 3). Speciﬁcally, in 18 stud-
ies, the OR for exclusive breast-feeding for
;2weeks ormorewas 0.73 (95%CI 0.58–
0.91) in early diagnosed disease and 0.75
(95% CI 0.60–0.95) for later diagnosed
disease. Similarly, in 24 studies, the OR
for exclusive breast-feeding for;3 months
or more was 0.86 (95% CI 0.71–1.03) in
early diagnosed disease and 0.90 (95% CI
0.76–1.05) for later diagnosed disease.
Supplementary Table 1 shows the
ﬁndings for exclusive breast-feeding
for ;2 weeks or more after adjustment
for potential confounders. The asso-
ciation between type 1 diabetes and ex-
clusive breast-feeding was little altered
after adjustment for any of these con-
founders individually, where possible, or
when adjustments were conducted for all
available confounders simultaneously.
CONCLUSIONSdThis pooled analysis
suggests that breast-feeding exclusively
in the early weeks of life could reduce
the risk of childhood onset type 1 diabetes
by 15%, based upon the highest quality
studies. This pooled analysis provides
little evidence that longer exclusive or
nonexclusive breast-feeding has a protec-
tive effect. However, ﬁrm conclusions are
difﬁcult to reach because of the marked
heterogeneity in the observed associations
between studies and the weaknesses in-
herent inmany of the included studies. The
observed association between exclusive
breast-feeding and type 1 diabetes could
not be explained by confounding from
established risk factors for diabetes in-
cluding maternal diabetes, birth weight,
gestational age, maternal age, birth order,
or Caesarean section delivery.
This is, to our knowledge, the ﬁrst
pooled analysis of individual participant
data on breast-feeding and diabetes. The
main strengths of using individual partic-
ipant data in this study was that it allowed
analysis to be conducted in similar cate-
gories of breast-feeding duration be-
tween studies and enabled adjustment of
associations for various confounders.
This analysis contains data from 43 stud-
ies and includes 9,874 patients with type
1 diabetes allowing the power to identify
associations of relatively small magni-
tude. Also, the analyses beneﬁted from
coverage of 95% of eligible cases from
studies identiﬁed by the comprehensive
search strategies. However, it remains
possible that studies with relevant data
were not identiﬁed by the searches. A
weakness of this pooled analysis was that
the majority of studies were questionnaire-
based case-control studies, and their
ﬁndings are based upon breast-feeding
information usually recalled over many
years, potentially resulting in recall and
other biases. There were only two cohort
studies (8,9) that prospectively recorded
breast-feeding at 2 weeks and 3 months,
but these contained relatively few patients
with type 1 diabetes, 31 and 24 cases, re-
spectively. Consequently, there is a need
for further studies prospectively or
routinely recording breast-feeding in
early life. Although attempts were made
to identify studies with lower risk of
bias (with higher response rates and ran-
domly selected population-based con-
trols), even in these studies, response
rates varied, and in many, recall bias is
possible. As with all observational stud-
ies, it is impossible to rule out the effect
of unmeasured confounding, for example,
by other infant food intake.
The association between breast-feeding
and type 1 diabetes differed markedly
between studies. This could reﬂect real
differences in the association in different
populations or biases speciﬁc to each
study. In studies with a low risk of bias,
less heterogeneity was observed, allowing
more conﬁdence to be placed on the
resulting pooled estimates.
The ﬁndings of our pooled analysis of
individual participant data differ from
two published literature-based meta-
analyses (3,4). The ﬁrst meta-analysis
(3) (containing studies conducted prior
to 1994) demonstrated a reduction in di-
abetes risk of 30%with breast-feeding.3
months, and a 35% reduction with exclu-
sive breast-feeding for .3 months. The
second meta-analysis (containing studies
conducted prior to 1996, many of which
were in the ﬁrst meta-analysis) demon-
strated a reduction in diabetes risk of
20% with breast-feeding for 3 months
and 40% for exclusive breast-feeding for
.3 months (4). In our pooled analysis,
there was little evidence of any reduction
in the risk of diabetes after 3 months of
breast-feeding (exclusive or nonexclusive).
Unfortunately, neither of the two earlier
meta-analyses presented estimates for
breast-feeding in the ﬁrst 2 weeks of life
to allow comparison with our results.
Both these meta-analyses were largely
based upon questionnaire-based case-
control studies, and the second meta-
analysis (4) highlighted that the observed
association could reﬂect methodological
weaknesses, particularly recall bias. The
authors suggested that mothers of chil-
dren with diabetes may more critically re-
member occasions when they deviated
from the breast-feeding recommendations
of health care personnel (4). As previously
discussed, themajority of studies included
in this pooled analysis were questionnaire-
based case-control studies and would also
be subject to this bias.
In 2007, the Agency for Healthcare
Research and Quality reviewed the evi-
dence of the effect of breast-feeding on
type 1 diabetes (13). However, the report
did not contain a meta-analysis because
their searches identiﬁed only 6 studies
after 1996 (up to 2007) when the pre-
vious meta-analyses were conducted, in
contrast to the 43 studies included in our
pooled analysis between 1996 and 2011.
The estimated OR of 0.75 for any breast-
feeding for 3 months from the Agency for
Healthcare Research and Quality report
(13) (based solely on the two previous
meta-analyses) has since been used to es-
timate the cost-effectiveness of breast-
feeding in the U.S. (14). Our results would
suggest that this OR of 0.75 may overesti-
mate any protective effect against type 1
diabetes and that consequently the cost-
effectiveness of breast-feeding with re-
spect to type 1 diabetes could also be
exaggerated. A recent narrative review (15)
commenting on the effects of breast-feeding
and complementary feeding noted that
the associations were controversial and
that contradictory outcomes had been ob-
served. Studies have also been conducted
intob-cell autoimmunity andbreast-feeding,
but the results have been mixed, with
some studies observing protective effects
of breast-feeding, whereas others have ob-
served no association [see Knip et al. (15)
for references].
This pooled analysis suggests that
initial exclusive breast-feeding may re-
duce diabetes risk, indicating that the
introduction of formula feeding may ex-
plain any association. The responsible
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mechanism is unclear, but researchers
have speculated (15) that breast-feeding
could protect against type 1 diabetes risk
by increasing gut permeability; previous
studies have shown that gut permeability
decreases faster in breastfed children (16)
or by reducing the risk of enterovirus in-
fections (17), which have been associated
with increased diabetes risk (18). Alterna-
tively, any increased risk of diabetes asso-
ciated with formula feeding could reﬂect
early exposure to a variety of cow’s milk
proteins [studies have shown children
with type 1 diabetes have increased con-
centrations of antibodies to dietary anti-
gens (19)], modiﬁcation of the gut
microﬂora (15), and increased weight
gain in early life [although one study sug-
gested that any effect of breast-feeding
was independent of weight gain (20)].
In our analysis, an association was only
observed for initial exclusive breast-
feeding (for $2 weeks) but not for ex-
clusive breast-feeding for $3 months.
This distinction may be real or could
reﬂect the relatively accurate maternal
recall of initial breast-feeding but less
accurate recall of the duration of feed-
ing, as previously suggested (3). If early
introduction of formula feeding is re-
sponsible then ongoing efforts to inves-
tigate alternative formula, such as the
Trial to Reduce Insulin-dependent Diabe-
tes Mellitus in the Genetically at Risk (21),
may be productive.
In conclusion, our pooled analysis
suggests that children who are initially
exclusively breast-fed have a small reduc-
tion in their risk of type 1 diabetes. This
ﬁnding is difﬁcult to interpret because the
associations varied markedly between
studies and because the results are based
primarily upon questionnaire-based case-
control studies, which could have been
affected by recall and other biases.
AcknowledgmentsdThis work was sup-
ported by National Institutes of Health grants
R01-DK-46498 and R01-DK-42316, the Chi-
nese Foundation of Health, a grant (DOH91-
TD1167) from the Department of Health,
Executive Yuan, Republic of China, theMinistry
for Science and Technology of the Republic
of Serbia through Contract 175042 (2011–
2014), a grant from the German Research
Foundation (HE 234/1-1), and the Research
Council of Norway (148359/330).
No potential conﬂicts of interest relevant to
this article were reported.
C.R.C., L.C.S., J.L., J.R., O.C., J.S., F.P.-B.,
A.M., S.G.G., E.J.K.W., E.S.S., M.J.G., K.R.,
L.-M.C., R.C.P., A.C., K.K., G.B., P.P., B.U.,
E.S., G.D., S.S., G.J., C.I.-T., C.E.d.B., K.H.,
V.B., E.S., A.-L.P., M.S., S.R., and C.C.P. re-
searched data. C.R.C., L.C.S., J.R., K.R., A.C.,
S.S., E.S., and M.S. were responsible for sta-
tistical analysis. C.R.C. wrote the manuscript.
C.R.C., L.C.S., J.L., J.R., O.C., J.S., F.P.-B.,
A.M., S.G.G., E.J.K.W., E.S.S., M.J.G., K.R.,
L.-M.C., R.C.P., A.C., K.K., G.B., P.P., B.U.,
E.S., G.D., S.S., G.J., C.I.-T., C.E.d.B., K.H.,
V.B., E.S., A.-L.P., M.S., S.R., and C.C.P. re-
viewed and edited the manuscript. C.R.C. is
the guarantor of this work and, as such, had
full access to all the data in the study and takes
responsibility for the integrity of the data and
the accuracy of the data analysis.
The authors thank A. Pezic (Murdoch
Children’s Research Institute, Parkville,
Victoria, Australia), R. Portuesi (Department of
Endocrinology and Diabetes, University Cam-
pus Bio-Medico, Rome, Italy), E. Weintraub
(Centers for Disease Control and Prevention,
Atlanta, GA), R. Rastmanesh (Clinical Nutrition
and Dietetics Department, Shahid Beheshti
University of Medical Sciences, Tehran, Iran),
J. Dorman (Department of Epidemiology,
Graduate School of Public Health, University
of Pittsburgh, Pittsburgh, PA), and M. Yang
(Department of Epidemiology, Graduate School
of Public Health, University of Pittsburgh,
Pittsburgh, PA) for support. The authors also
thank G. Soltész (University of Pecs, Pecs,
Hungary) and G. Dahlquist (Umea University,
Umea, Sweden), coordinators of the EURODIAB
Substudy.
References
1. Patterson CC, Dahlquist GG, Gyürüs E,
Green A, Soltész G; EURODIAB Study
Group. Incidence trends for childhood
type 1 diabetes in Europe during 1989-
2003 and predicted new cases 2005-20:
a multicentre prospective registration
study. Lancet 2009;373:2027–2033
2. Hirschhorn JN. Genetic epidemiology of
type 1 diabetes. Pediatr Diabetes 2003;4:
87–100
3. Gerstein HC. Cow’s milk exposure and
type I diabetes mellitus. A critical over-
view of the clinical literature. Diabetes
Care 1994;17:13–19
4. Norris JM, Scott FW. A meta-analysis of
infant diet and insulin-dependent di-
abetes mellitus: do biases play a role?
Epidemiology 1996;7:87–92
5. Stewart LA, Tierney JF. To IPD or not to
IPD? Advantages and disadvantages of
systematic reviews using individual patient
data. Eval Health Prof 2002;25:76–97
6. Owen CG, Whincup PH, Kaye SJ, et al.
Does initial breastfeeding lead to lower
blood cholesterol in adult life? A quanti-
tative review of the evidence. Am J Clin
Nutr 2008;88:305–314
7. Stukel TA, Demidenko E, Dykes J,
Karagas MR. Two-stage methods for the
analysis of pooled data. Stat Med 2001;20:
2115–2130
8. Savilahti E, Saarinen KM. Early infant
feeding and type 1 diabetes. Eur J Nutr
2009;48:243–249
9. Ponsonby AL, Pezic A, Cochrane J, et al.
Infant anthropometry, early life infection,
and subsequent risk of type 1 diabetes
mellitus: a prospective birth cohort study.
Pediatr Diabetes 2011;12:313–321
10. DIAMOND Project Group. Incidence and
trends of childhood Type 1 diabetes
worldwide 1990-1999. Diabet Med 2006;
23:857–866
11. Dahlquist GG, Patterson C, Soltesz G.
Perinatal risk factors for childhood type 1
diabetes in Europe. The EURODIAB
Substudy 2 Study Group. Diabetes Care
1999;22:1698–1702
12. Sadauskaite-Kuehne V, Ludvigsson J,
Padaiga Z, Jasinskiene E, Samuelsson U.
Longer breastfeeding is an independent
protective factor against development of
type 1 diabetes mellitus in childhood. Di-
abetes Metab Res Rev 2004;20:150–157
13. Ip S, Chung M, Raman G, et al. Breast-
feeding and Maternal and Infant Health
Outcomes in Developed Countries. Evidence
Report/Technology Assessment No. 153.
Rockville, MD, Agency for Healthcare
Research and Quality, 2007
14. Bartick M, Reinhold A. The burden of
suboptimal breastfeeding in the United
States: a pediatric cost analysis. Pediatrics
2010;125:e1048–e1056
15. KnipM,Virtanen SM, AkerblomHK. Infant
feeding and the risk of type 1 diabetes. Am J
Clin Nutr 2010;91:1506S–1513S
16. CatassiC, BonucciA,CoppaGV,Carlucci A,
Giorgi PL. Intestinal permeability changes
during the ﬁrst month: effect of natural
versus artiﬁcial feeding. J Pediatr Gastro-
enterol Nutr 1995;21:383–386
17. Sadeharju K, Knip M, Virtanen SM, et al.;
Finnish TRIGR Study Group. Maternal
antibodies in breast milk protect the child
from enterovirus infections. Pediatrics
2007;119:941–946
18. Yeung WC, Rawlinson WD, Craig ME.
Enterovirus infection and type 1 diabetes
mellitus: systematic review and meta-
analysis of observational molecular stud-
ies. BMJ 2011;342:d35
19. Savilahti E, Akerblom HK, Tainio VM,
Koskimies S. Children with newly di-
agnosed insulin dependent diabetes mel-
litus have increased levels of cow’s milk
antibodies. Diabetes Res 1988;7:137–140
20. Hyppönen E, Kenward MG, Virtanen SM,
et al. Infant feeding, early weight gain, and
risk of type 1 diabetes. Childhood Di-
abetes in Finland (DiMe) Study Group.
Diabetes Care 1999;22:1961–1965
21. Knip M, Virtanen SM, Becker D, Dupré J,
Krischer JP, Åkerblom HK; TRIGR Study
Group. Early feeding and risk of type 1 di-
abetes: experiences from the Trial to Re-
duce Insulin-dependent diabetes mellitus
in the Genetically at Risk (TRIGR). Am J
Clin Nutr 2011;94(Suppl.):1814S–1820S
care.diabetesjournals.org DIABETES CARE, VOLUME 35, NOVEMBER 2012 2225
Cardwell and Associates
